Zepp Health Corporation (ZEPP) Revenue History
Annual and quarterly revenue from 2015 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ZEPP Revenue Growth
Revenue Breakdown (FY 2023)
ZEPP's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
By Geography
ZEPP Revenue Analysis (2015–2024)
As of May 8, 2026, Zepp Health Corporation (ZEPP) generated trailing twelve-month (TTM) revenue of $1.68 billion, reflecting explosive growth of +81.3% year-over-year. The most recent quarter (Q3 2025) recorded $539.6 million in revenue, up 26.3% sequentially.
Looking at the longer-term picture, ZEPP's 5-year compound annual growth rate (CAGR) stands at -25.5%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $6.17 billion in 2021.
Revenue diversification analysis shows ZEPP's business is primarily driven by Manufactured Product, Other (74%), and Product (26%). With over half of revenue concentrated in Manufactured Product, Other, the company maintains significant focus in this area while developing other growth vectors.
When compared to Technology sector peers including GRMN (+15.7% YoY), FOSL (-12.3% YoY), and SMPL (+6.3% YoY), ZEPP has outperformed the peer group in terms of revenue growth. Compare ZEPP vs GRMN →
ZEPP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ZEPPCurrent | $1.7B | +81.3% | -25.5% | -25.9% | |
 GRMN | $7.2B | +15.7% | +11.6% | 25.9% | |
 FOSL | $1.0B | -12.3% | -9.0% | 2.3% | |
 SMPL | $1.5B | +6.3% | +12.2% | 15.1% | |
 AAPL | $416.2B | +12.8% | +8.7% | 32.0% | |
 FITB | $13.0B | - | - | 22.3% |
ZEPP Historical Revenue Data (2015–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $1.33B | -46.6% | $512.9M | 38.5% | $-345,041,274 | -25.9% |
| 2023 | $2.50B | -40.8% | $653.7M | 26.2% | $-215,522,459 | -8.6% |
| 2022 | $4.22B | -31.7% | $817.2M | 19.4% | $-417,447,389 | -9.9% |
| 2021 | $6.17B | +1.4% | $1.29B | 20.9% | $92.7M | 1.5% |
| 2020 | $6.08B | +4.9% | $1.26B | 20.7% | $164.7M | 2.7% |
| 2019 | $5.80B | +53.0% | $1.46B | 25.3% | $619.0M | 10.7% |
| 2018 | $3.79B | +89.6% | $976.1M | 25.8% | $380.0M | 10.0% |
| 2017 | $2.00B | +22.7% | $482.3M | 24.1% | $177.4M | 8.9% |
| 2016 | $1.63B | +75.9% | $288.9M | 17.7% | $14.0M | 0.9% |
| 2015 | $925.4M | - | $114.2M | 12.3% | $-41,408,376 | -4.5% |
See ZEPP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZEPP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZEPP vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonZEPP — Frequently Asked Questions
Quick answers to the most common questions about buying ZEPP stock.
Is ZEPP's revenue growth accelerating or slowing?
ZEPP revenue is accelerating at +81.3% year-over-year, exceeding the 5-year CAGR of -25.5%. TTM revenue reached $1.7B. Growth momentum has increased versus prior periods.
What is ZEPP's long-term revenue growth rate?
Zepp Health Corporation's 5-year revenue CAGR of -25.5% reflects the sustained expansion pattern. Current YoY growth of +81.3% is above this long-term average.
How is ZEPP's revenue distributed by segment?
ZEPP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2024 are available for download. Segment mix reveals concentration and diversification trends.